In the US, Hepsera (adefovir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat Hepatitis B.
Ingredient matches for Hepsera
Adefovir is reported as an ingredient of Hepsera in the following countries:
Adefovir dipivoxil (a derivative of Adefovir) is reported as an ingredient of Hepsera in the following countries:
- Czech Republic
- Hong Kong
- New Zealand
- United Kingdom
- United States
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.